The FDA Approved Remdesivir Based on a Trial in Which 3 out of 53 Children Died

May 5, 2022 in News by RBN Staff

source:  needtoknownews

 

May 2, 2022 Dr. Meryl Nass and Lorphic Web 0

Pixabay
Remdesivir has now been approved by the FDA in children and babies as young as 28 days old, weighing as little as six pounds. Gilead, the manufacturer of remdesivir performed its human clinical drug trial using only 53 children, and three of them died. Dr. Meryl Nass said, “Over 70% had an adverse reaction, 21% had a serious adverse event, and three of the children died. Because there was no control group, it’s unclear how either Gilead or the FDA determined that the drug benefited children, because there’s nothing to compare it to.” The drug received approval quickly which may be due to Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) and the US Army both receiving a portion of the royalties for the drug.

  • Save

Link for video:    https://rumble.com/v133ckl-child-sacrifice-the-fda-approved-remdesivir.html

Child Sacrifice: The FDA Approved Remdesivir Based on a Trial in Which 3 out of 53 Children Died

The trial was conducted by Gilead, the developer of remdesivir, and there was no control group.

The mortality rate of children with no treatment against COVID is 0.005% (1 in 20,000 die).

Based on this trial, the mortality rate of children with remdesivir treatment is 5.66% (1 in 17.7 die).

Dr. Meryl Nass: “Over 70% had an adverse reaction, 21% had a serious adverse event, and three of the children died. Because there was no control group, it’s unclear how either Gilead or the FDA determined that the drug benefited children, because there’s nothing to compare it to.”

Read full article here…

Comments Off on The FDA Approved Remdesivir Based on a Trial in Which 3 out of 53 Children Died